July 19, 2024 Experience Clariane €92 million reserved capital increase and €237 million rights offering We advised Clariane on its refinancing transactions
July 11, 2024 Experience IDEAYA Biosciences $302.5 million equity offering The common stock is listed on the Nasdaq Global Select Market
July 2, 2024 Experience Recursion Pharmaceuticals $230 million follow-on offering The shares are listed on the Nasdaq Global Select Market
July 2, 2024 Experience InflaRx $75 million at-the-market offering The shares are listed on the Nasdaq Global Market
July 2, 2024 Experience CCC Intelligent Solutions Holdings $339 million secondary offering The shares are listed on the Nasdaq Global Select Market
June 28, 2024 Experience Pepkor Holdings ZAR 9 billion secondary offering The accelerated bookbuild transaction represented approximately 13.6% of Pepkor’s issued share capital
June 20, 2024 Experience QXO $3.5 billion private placement This is the largest PIPE offering in the industrials sector ever
June 14, 2024 Experience Atour Lifestyle Holdings $194.4 million secondary offering We advised Atour on a secondary offering of ADSs